• A comprehensive evaluation method for anti-SARS-CoV-2 drugs was established based on qPCR, TCID, and immunofluorescence. • A significant antiviral effect of rHuIFN-α1b was shown in Vero and Calu-3 cells. • rHuIFN-α1b has a good potential in the application of anti-COVID-19 therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786678 | PMC |
| http://dx.doi.org/10.1016/j.virs.2022.01.031 | DOI Listing |
Publication Analysis
Top Keywords
recombinant human
4
human interferon-α1b
4
interferon-α1b inhibits
4
inhibits sars-cov-2
4
sars-cov-2 better
4
better interferon-α2b
4
interferon-α2b vitro
4
vitro •
4
• comprehensive
4
comprehensive evaluation
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!